Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

Below are the newest and most recently updated Shortage and Discontinuation reports.

Drug pills

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
FLORINEF PALADIN LABS INC Anticipated shortage 0.1MG Updated Report 2019-06-20 87124
ROSUVASTATIN SIVEM PHARMACEUTICALS ULC Actual shortage 40MG Updated Report 2019-06-20 85435
TEPADINA ADIENNE SA Anticipated shortage 15MG Updated Report 2019-06-20 86671
NALOXONE HYDROCHLORIDE INJECTION USP TELIGENT OU Resolved 0.4MG Updated Report 2019-06-20 65888
ROPINIROLE SANIS HEALTH INC Actual shortage 0.25MG Updated Report 2019-06-20 87069
LABETALOL HYDROCHLORIDE INJECTION, USP MYLAN PHARMACEUTICALS ULC Actual shortage 5MG Updated Report 2019-06-20 78454
CANDESARTAN HCT SIVEM PHARMACEUTICALS ULC Actual shortage 12.5MG 16MG Updated Report 2019-06-20 84315
CILOXAN NOVARTIS PHARMACEUTICALS CANADA INC Actual shortage 0.3% Updated Report 2019-06-20 85629
KETOROLAC AA PHARMA INC Actual shortage 0.5% Updated Report 2019-06-20 87054
ALPRAZOLAM PRO DOC LIMITEE Actual shortage 1MG Updated Report 2019-06-19 82426

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
PRO-NAPROXEN EC - 375 PRO DOC LIMITEE To be discontinued 375MG Updated Report 2019-06-19 84067
APO-GEMFIBROZIL CAP 300MG USP APOTEX INC Discontinued New Report 2019-06-12 86557
APO-EXEMESTANE APOTEX INC Discontinued New Report 2019-06-12 86552
APO-CIPROFLOX APOTEX INC Discontinued New Report 2019-06-12 86547
APO-CEFPROZIL APOTEX INC Discontinued New Report 2019-06-12 86542
APO-TOLTERODINE APOTEX INC Discontinued 2MG Updated Report 2019-06-12 60828
APO-RISPERIDONE APOTEX INC Discontinued 3.0MG Updated Report 2019-06-12 60750
APO OXAZEPAM TAB 30MG APOTEX INC Discontinued 30MG Updated Report 2019-06-12 60681
APO-METFORMIN 850 MG TABLETS APOTEX INC Discontinued 850MG Updated Report 2019-06-12 40778
APO-BROMAZEPAM - TAB 3MG APOTEX INC Discontinued 3MG Updated Report 2019-06-12 60307
APO-CAPTO TAB 6.25MG APOTEX INC Discontinued 6.25MG Updated Report 2019-06-12 60339
TRAMADOL / ACETAMINOPHEN SIVEM PHARMACEUTICALS ULC To be discontinued 37.5MG 325MG New Report 2019-06-12 86439
BICALUTAMIDE SIVEM PHARMACEUTICALS ULC To be discontinued 50MG New Report 2019-06-12 86436
BICALUTAMIDE SIVEM PHARMACEUTICALS ULC To be discontinued 50MG New Report 2019-06-12 86431
GONAL-F EMD SERONO A DIVISION OF EMD INC CANADA To be discontinued 77MCG Updated Report 2019-06-12 75742
GONAL-F EMD SERONO A DIVISION OF EMD INC CANADA To be discontinued 33MCG Updated Report 2019-06-12 75734
DIPROLENE MERCK CANADA INC To be discontinued 0.5MG Updated Report 2019-06-11 68027
HYCAMTIN NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 4MG Updated Report 2019-06-11 8129
MYOCHRYSINE SANOFI-AVENTIS CANADA INC Discontinued 50MG New Report 2019-06-10 86073
MYOCHRYSINE SANOFI-AVENTIS CANADA INC Discontinued 25MG New Report 2019-06-10 86070